Physiatrist for Anxiety: Clinical Role and Somatic Treatment

The Anxiety Solve Editorial Collective | Updated: March 2026

Executive Summary: Physiatry in Psychiatric Care

Physiatrist for anxiety referral pathways involve utilizing Physical Medicine and Rehabilitation (PM&R) to address the somatic manifestations of distress (ICD-11: 6C20) that persist beyond the scope of conventional psychiatric or psychological intervention. These medical doctors — board-certified specialists in physical medicine and rehabilitation — focus on the functional restoration of the body’s physiological response to chronic stress, employing non-pharmacological and integrative interventions that target the musculoskeletal, autonomic, and neuroendocrine systems as primary therapeutic substrates.

The physiatric approach to anxiety-related somatic dysfunction is grounded in the recognition that chronic psychological distress produces measurable, addressable changes in physical function — postural dysregulation, myofascial tension patterns, autonomic nervous system dysbalance — that perpetuate the anxiety cycle through somatic-visceral manifestations that pharmacological and cognitive interventions alone may not adequately address. Understanding when and how to incorporate physiatric consultation within a comprehensive anxiety treatment framework represents an important and frequently overlooked dimension of truly integrative care.

What does a physiatrist do for anxiety?

A physiatrist addressing anxiety-related presentations focuses on the physiological cascade through which psychological distress becomes encoded in the body’s musculoskeletal and autonomic systems — the sustained muscle tension, postural collapse, respiratory pattern dysregulation, and autonomic nervous system dysbalance that both result from and perpetuate the anxious state. Their clinical scope includes the assessment and treatment of somatic symptom disorder (ICD-11: 6C20), myofascial pain syndromes whose nociceptive input maintains sympathetic hyperarousal, and the rehabilitation of autonomic nervous system recalibration through structured non-pharmacological interventions including biofeedback, therapeutic exercise prescription, manual therapy coordination, and functional restoration protocols. The physiatrist’s role in the anxiety treatment team is therefore additive rather than overlapping with psychiatric and psychological care: they address the body-based maintaining factors of the anxiety disorder that persist as physiological substrates even when cognitive and neurochemical dimensions are being concurrently managed, providing the Anxiety Solve somatic protocols framework with a medically supervised foundation for physical functional restoration.

Diagnostic Distinction: Physiatrist vs. Psychiatrist

Whole-Body Function vs. Neurochemical Mood Stabilization

The fundamental clinical distinction between physiatry and psychiatry in the context of anxiety management lies in the primary level of intervention and the conceptual model of pathology each specialty addresses. The psychiatrist approaches anxiety as a disorder of neurochemical and neurobiological regulation — targeting synaptic transmission, receptor sensitivity, and the neural circuits of threat appraisal and emotional regulation through pharmacological and, in collaboration with psychologists, psychotherapeutic means.

The physiatrist approaches anxiety’s somatic dimension as a disorder of functional physical system integration — targeting the musculoskeletal patterns, respiratory mechanics, autonomic tone, and proprioceptive signaling that constitute the body’s contribution to the maintenance of the anxious state. This distinction is not hierarchical but complementary: the two specialties address different levels of the biopsychosocial system, and their integration produces a more complete treatment model than either specialty alone can provide.

The Functional Restoration Model

Physiatry’s core clinical framework — functional restoration — applies with particular relevance to anxiety presentations that have produced measurable physical dysfunction. Chronic sympathetic hyperactivation produces documented changes in the musculoskeletal system: sustained elevation of trapezius and paraspinal muscle tone, forward head posture that mechanically compromises respiratory excursion, diaphragmatic restriction that enforces a shallow thoracic breathing pattern, and chronic myofascial trigger point development that generates ongoing nociceptive input maintaining central sensitization.

These physical changes are not merely secondary to the anxiety — they become maintaining factors in their own right, generating afferent signals that the brain interprets as threat-confirming body states and that sustain the physiological arousal cycle independently of the original psychological triggers. The physiatrist’s functional restoration approach targets these physical maintaining factors through evidence-based physical medicine interventions, interrupting the body-level component of the anxiety maintenance cycle in a manner that cognitive and pharmacological interventions cannot directly achieve.

Physiologic vs. Cognitive Treatment Approaches

Specialty	Core Focus	Common Interventions
Physiatry (PM&R)	Functional restoration of the somatic systems — musculoskeletal, autonomic, respiratory, and proprioceptive — that perpetuate the physiological anxiety cycle through body-level maintaining factors	Biofeedback (EMG and HRV), therapeutic exercise prescription, postural rehabilitation, myofascial release coordination, diaphragmatic breathing retraining, aquatic therapy, and autonomic nervous system recalibration protocols
Psychiatry	Neurochemical and neurobiological regulation of the mood and anxiety systems through pharmacological modulation of neurotransmitter systems and receptor sensitivity, with oversight of the medical dimensions of psychiatric care	Pharmacotherapy (SSRIs, SNRIs, anxiolytics, beta-blockers), psychiatric evaluation and diagnosis, medication management, monitoring for pharmacological adverse effects, and coordination of complex psychiatric comorbidities
Clinical Psychology	Cognitive, behavioral, and affective processing dimensions of anxiety through structured psychotherapeutic intervention targeting the cognitive schemas, behavioral avoidance patterns, and emotional regulation deficits that maintain the disorder	Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), Acceptance and Commitment Therapy (ACT), schema therapy, and evidence-based psychological assessment and outcome monitoring

Physiatric Interventions: Clinical Modalities in Detail

Biofeedback for Autonomic Recalibration

Biofeedback represents the physiatric intervention with the most direct and robust evidence base for anxiety-related autonomic dysregulation. Electromyographic (EMG) biofeedback provides real-time visual or auditory feedback of muscle electrical activity, enabling patients to develop conscious awareness of and voluntary control over chronic muscle tension patterns that they were previously unable to perceive or regulate.

Heart rate variability (HRV) biofeedback — in which the patient learns to modulate respiratory rate and depth to maximize beat-to-beat variation in heart rate — directly trains the baroreflex sensitivity and parasympathetic tone that are consistently reduced in anxiety disorders. The evidence base for HRV biofeedback in generalized anxiety disorder includes multiple randomized controlled trials demonstrating significant reductions in anxiety severity, improvements in HRV indices, and normalization of cortisol diurnal rhythm, with effect sizes comparable to pharmacological first-line agents for some patient subgroups.

Therapeutic Exercise Prescription

The physiatrist’s role in therapeutic exercise prescription for anxiety differs from general exercise recommendations in its specificity and individualization. Rather than prescribing generic aerobic activity, the physiatrist conducts a functional assessment of the patient’s postural patterns, respiratory mechanics, movement quality, and autonomic response to physical exertion before designing an individualized exercise protocol that addresses the specific physical dysfunction contributing to the anxiety maintenance cycle.

For patients with chronic postural hyperarousal — a sustained pattern of protective muscular bracing that maintains sympathetic tone through ongoing proprioceptive signaling — the exercise prescription may prioritize progressive relaxation-based movement modalities such as yoga therapy or tai chi, which have demonstrated efficacy in reducing muscle tension, improving HRV, and reducing anxiety severity in controlled studies. For patients with deconditioning-related anxiety amplification — where physical exertion produces symptom misinterpretation and avoidance — graded exercise protocols with interoceptive exposure components may be appropriate.

Myofascial and Manual Therapy Coordination

The physiatrist frequently coordinates referral to physical therapists and osteopathic practitioners specializing in myofascial release and manual therapy techniques for the treatment of anxiety-associated musculoskeletal dysfunction. Myofascial trigger points — hyperirritable foci within taut muscle bands that generate local and referred pain — are consistently identified in patients with chronic anxiety and contribute to the ongoing nociceptive afferent load that maintains central sensitization and sympathetic hyperactivation.

The clinical evidence for manual therapy in anxiety-associated myofascial dysfunction includes studies documenting reductions in trigger point sensitivity, improvements in range of motion, and reductions in sympathetic arousal markers following structured myofascial intervention. The physiatrist’s role is to establish the clinical indication, coordinate the referral, monitor treatment response, and integrate the outcomes of manual therapy within the broader functional restoration protocol.

Clinical Scope of Practice: When to Refer to a Physiatrist

Primary Indications for Physiatric Consultation in Anxiety Presentations

The following clinical presentations represent the primary indications for physiatric consultation within a comprehensive anxiety treatment framework, where the somatic component of the presentation is sufficiently prominent or functionally limiting to warrant dedicated physical medicine evaluation:

• Fibromyalgia-related anxiety: patients with fibromyalgia syndrome (ICD-11: MG30.01) whose widespread chronic pain generates continuous nociceptive afferent signaling that maintains central sensitization and sympathetic hyperarousal; the physiatrist addresses both the pain syndrome and its autonomic consequences through integrated physical medicine protocols
• Post-traumatic injury stress with somatic fixation: patients who have sustained musculoskeletal injury and developed anxiety-driven hypervigilance to somatic sensations, producing symptom amplification, catastrophic misinterpretation of normal physical sensations, and avoidance of physical activity; the physiatrist provides graded functional restoration alongside psychologist-managed exposure
• Chronic postural hyperarousal syndrome: patients with sustained forward head posture, thoracic kyphosis, and diaphragmatic restriction producing a chronic respiratory pattern characterized by upper chest breathing, reduced tidal volume, and low-grade hypocapnia that maintains autonomic arousal; the physiatrist targets postural rehabilitation and respiratory retraining
• Somatic symptom disorder with functional impairment: patients meeting ICD-11 criteria for somatic symptom disorder (6C20) whose anxiety is mediated through and expressed primarily as physical symptoms including non-cardiac chest pain, functional dyspnea, tension headache, and chronic pelvic or abdominal pain; for comprehensive functional impairment evaluations in these presentations, structured physiatric assessment provides medically credible documentation of functional status
• Chronic pain comorbidity with anxiety sensitization: patients in whom chronic pain and anxiety have entered a mutually maintaining cycle through shared mechanisms of central sensitization, catastrophizing, and fear-avoidance behavior; the physiatrist addresses the pain component with functional restoration while coordinating with the clinical psychologist for concurrent fear-avoidance rehabilitation
• Autonomic nervous system dysfunction with somatic presentation: patients with documented dysautonomia features — postural tachycardia, orthostatic intolerance, vasovagal instability — whose autonomic instability generates anxiety-amplifying somatic sensations; the physiatrist provides structured autonomic conditioning protocols alongside pharmacological management when indicated

Secondary Indications and Adjunctive Roles

Beyond the primary indications above, physiatric consultation may provide adjunctive value in the following clinical scenarios:

• Patients who have achieved partial response to first-line cognitive and pharmacological interventions but retain significant somatic symptoms that limit functional engagement in psychotherapy and exposure exercises
• Patients with prominent physical deconditioning secondary to anxiety-driven activity avoidance, for whom graded exercise rehabilitation is a prerequisite for engagement with behavioral activation components of CBT
• Patients preparing for or recovering from psychiatric hospitalization who require structured functional restoration to support their return to occupational and social functioning
• Athletes and performers whose anxiety presentations include prominent somatic components affecting physical performance, where the physiatrist’s sports medicine expertise adds a relevant dimension to the treatment team

Integration with the Multidisciplinary Anxiety Treatment Team

Treatment Goal Alignment Across Specialties

Effective integration of physiatric care within the multidisciplinary anxiety treatment team requires explicit alignment of treatment goals across all treating clinicians, ensuring that the physiatric functional restoration objectives are coherent with and supportive of the concurrent psychiatric and psychological treatment objectives. This alignment requires regular inter-professional communication — shared outcome measures, coordinated goal-setting with patient participation, and explicit discussion of how physiatric interventions are expected to support engagement in psychotherapeutic and pharmacological treatment.

The most common integration challenge is the potential for physiatric somatic focus to inadvertently reinforce somatic hypervigilance in patients with health anxiety or somatic symptom disorder, where excessive focus on physical symptoms may amplify rather than reduce anxiety-driven body monitoring. The physiatrist managing anxiety-comorbid presentations should coordinate with the patient’s psychologist to ensure that somatic interventions are framed within a functional restoration rather than a symptom-focused model, and that the language used to describe physical findings does not contribute to catastrophic misinterpretation.

Outcome Measurement in Physiatric Anxiety Management

Physiatric outcome measurement in anxiety presentations requires instruments that capture both physical function and anxiety severity to document the bidirectional relationship between somatic improvement and anxiety reduction. Recommended outcome domains include HRV indices as biomarkers of autonomic recalibration, validated myofascial pain severity instruments, functional capacity assessments, and standardized anxiety severity scales used concurrently with the patient’s psychiatric and psychological treating team to enable integrated outcome tracking across the full biopsychosocial treatment model.

FAQ

Editorial Note

This review was produced by the Anxiety Solve Editorial Collective with the objective of providing a clinically rigorous, technically accurate analysis of the physiatric contribution to comprehensive anxiety management. The Collective declares no commercial relationships with any rehabilitation equipment manufacturers, biofeedback device companies, or clinical service providers referenced in this document. All clinical claims are referenced to peer-reviewed literature and specialty organization guidelines.

References

American Academy of Physical Medicine and Rehabilitation (AAPM&R). Definition and scope of physical medicine and rehabilitation. Rosemont, IL: AAPM&R; 2023. Available at: https://www.aapmr.org

Yunus, M. B. The prevalence of fibromyalgia in other chronic pain conditions. Pain Research and Treatment, 2012; 2012: 584573.

Gevirtz, R. The promise of heart rate variability biofeedback: evidence-based applications. Biofeedback, 2013; 41(3): 110–120.

Lehrer, P. M. y Gevirtz, R. Heart rate variability biofeedback: how and why does it work? Frontiers in Psychology, 2014; 5: 756.

Simons, D. G., Travell, J. G. y Simons, L. S. Travell and Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual. Segunda edición. Baltimore: Williams and Wilkins; 1999.

Porges, S. W. The polyvagal theory: neurophysiological foundations of emotions, attachment, communication, and self-regulation. New York: W. W. Norton and Company; 2011.

Mayo Clinic Proceedings. Somatic symptom disorder and related conditions: diagnostic and therapeutic challenges. Mayo Clinic Proceedings, 2021; 96(8): 2114–2126.

World Health Organization. International Classification of Diseases, Eleventh Revision (ICD-11). Code 6C20: Somatic symptom disorder. Geneva: WHO; 2022. Available at: https://icd.who.int

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, D.C.: American Psychiatric Association Publishing; 2022.

Cramer, H. et al. Yoga for anxiety: a systematic review and meta-analysis of randomized controlled trials. Depression and Anxiety, 2018; 35(9): 830–843.

Wipfli, B. M., Rethorst, C. D. y Landers, D. M. The anxiolytic effects of exercise: a meta-analysis of randomized trials and dose-response analysis. Journal of Sport and Exercise Psychology, 2008; 30(4): 392–410.

National Institute for Health and Care Excellence (NICE). Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE Guideline NG193. London: NICE; 2021. Available at: https://www.nice.org.uk